Isolagen, Inc. Postpones Annual Meeting
September 24 2007 - 5:00PM
PR Newswire (US)
EXTON, Pa., Sept. 24 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc.
(AMEX:ILE) announced today that it is postponing its 2007 Annual
Meeting of Stockholders scheduled for tomorrow in Nashville,
Tennessee in order to obtain a quorum of shareholder votes. The
company has rescheduled the annual meeting for Monday, November 5,
2007 at 1:00 p.m. in Philadelphia, Pennsylvania. The record date
for stockholders entitled to vote at the meeting remains the close
of business on September 5, 2007. Stockholders who have previously
sent in proxy cards or given instructions to brokers do not need to
recast their votes. About Isolagen, Inc. Isolagen(TM), Inc.
(AMEX:ILE) is an aesthetic and therapeutic company committed to
developing and commercializing scientific advances and innovative
technologies. The company's technology platform includes the
Isolagen Process(TM), a cell processing system for skin and tissue
rejuvenation which is currently in clinical development for a broad
range of aesthetic and therapeutic applications including wrinkles,
acne scars, burns and periodontal disease. Isolagen also
commercializes a scientifically-advanced line of skincare systems
through its majority-owned subsidiary, Agera(R) Laboratories, Inc.
For additional information, please visit http://www.isolagen.com/.
Isolagen Forward Looking Statements All statements in this news
release that are not based on historical fact are "forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995 and the provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. While management has
based any forward-looking statements contained herein on its
current expectations, the information on which such expectations
were based may change. These forward-looking statements rely on a
number of assumptions concerning future events and are subject to a
number of risks, uncertainties, and other factors, many of which
are outside of our control, that could cause actual results to
materially differ from such statements. Such risks, uncertainties,
and other factors include, but are not necessarily limited to,
those set forth under Item 1A "Risk Factors" in the Company's
Annual Report on Form 10-K for the year ended December 31, 2006, as
updated in "Item 1A. Risk Factors" in the Company's Quarterly
Reports on Form 10-Q. We operate in a highly competitive and
rapidly changing environment, thus new or unforeseen risks may
arise. Accordingly, investors should not place any reliance on
forward-looking statements as a prediction of actual results. We
disclaim any intention to, and undertake no obligation to, update
or revise any forward-looking statements. Readers are also urged to
carefully review and consider the other various disclosures in the
Company's Annual Report on Form 10-K for the year ended December
31, 2006, as well as other public filings with the SEC since such
date. DATASOURCE: Isolagen(TM), Inc. CONTACT: Media, Mike Beyer of
Sam Brown Inc., +1-773-463-4211, , for Isolagen, Inc.; Investors,
Charles Huiner of Isolagen, Inc., +1-484-713-6200, Web site:
http://www.isolagen.com/
Copyright
Isolagen (AMEX:ILE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Isolagen (AMEX:ILE)
Historical Stock Chart
From Jul 2023 to Jul 2024